RxDoctor Payments Data

Gebhard Wagener, MD

Critical Care Medicine · New York, NYNPI 1942354212

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 2 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. That places this record below the midpoint for critical care medicine clinicians in NY, where the typical reported total is $204.

$198in general payments, 2019–2025

Across 2 payments — averaging $99.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Werfen USA LLC$115
  • Heron Therapeutics, Inc.$84
$572,385in research payments, 2019–2025

Across 24 payments — averaging $23,849 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Edwards Lifesciences$473K
  • BD$99K

What the payments were for

  • Food & beverage$198100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Werfen USA LLC1$115
Heron Therapeutics, Inc.1$84

How this compares

$198 in reported general payments places this provider in the 45th percentile of 442 critical care medicine providers in New York.

See all critical care medicine providers in New York

Medicare billing

Part B allowed, 2024
$53,745
Medicare patients
96
Services billed
216

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other critical care medicine in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →